Neeraj Agarwal
- Oncology top 10%
- PARP inhibition in cancer therapy 10
- Cancer Immunotherapy and Biomarkers 4
-
- Prostate Cancer Treatment and Research 17
- Prostate Cancer Diagnosis and Treatment 4
- Advanced Breast Cancer Therapies 3
-
- Radiopharmaceutical Chemistry and Applications 4
-
- Multiple Myeloma Research and Treatments 3
-
- Protein Degradation and Inhibitors 2
- Co-authors
- Fred SaadJoan CarlesNeal D. ShoreSumanta K. PalFrank PriouWinald R. GerritsenChris ParkerSiobhan Ng
- Partner nations
- United StatesSpainFrance
In The Last Decade
Neeraj Agarwal
23 papers receiving 498 citations
Peers
Comparison fields: 5 of 64
- Oncology 252
- Pulmonary and Respiratory Medicine 270
- Immunology 158
- Cancer Research 72
- Radiology, Nuclear Medicine and Imaging 70
Countries citing papers authored by Neeraj Agarwal
This map shows the geographic impact of Neeraj Agarwal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neeraj Agarwal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neeraj Agarwal more than expected).
Fields of papers citing papers by Neeraj Agarwal
This network shows the impact of papers produced by Neeraj Agarwal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neeraj Agarwal. The network helps show where Neeraj Agarwal may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Neeraj Agarwal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 11 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 1 | |
| 5 | 2025 | 2 | |
| 6 | 2025 | 3 | |
| 7 | 2024 | 4 | |
| 8 | 2024 | 0 | |
| 9 | 2024 | 3 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 5 | |
| 12 | 2022 | 26 | |
| 13 | 2021 | 63 | |
| 14 | 2021 | 1 | |
| 15 | 2021 | 1 | |
| 16 | 2020 | 1 | |
| 17 | 2019 | 183 | |
| 18 | 2016 | 48 | |
| 19 | 2015 | 31 | |
| 20 | 2015 | 110 |
About Neeraj Agarwal
Neeraj Agarwal is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Hematology, having authored 26 papers that have together received 509 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (17 papers), PARP inhibition in cancer therapy (10 papers), Radiopharmaceutical Chemistry and Applications (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Prostate Cancer Diagnosis and Treatment (4 papers), Advanced Breast Cancer Therapies (3 papers), Multiple Myeloma Research and Treatments (3 papers) and Protein Degradation and Inhibitors (2 papers). The work is most often cited by research in Oncology (252 citations), Pulmonary and Respiratory Medicine (270 citations) and Immunology (158 citations). Neeraj Agarwal has collaborated with scholars based in United States, Spain and France. Frequent co-authors include Fred Saad, Joan Carles, Neal D. Shore, Sumanta K. Pal, Frank Priou, Winald R. Gerritsen, Chris Parker, Siobhan Ng, Liddy Chen and Christopher R. Heery. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.